Athymic (nude) mice for pharmacology; rabbits, guinea pigs, mice for biocompatibility
“Species: Athymic mice, 6-8 weeks old; the number, strain and sex were not provided in the study report”
✓ VerifiedFDA pharmacology/toxicology review, p. 17Source ↗
Why that species
Immunodeficient mice used so human cells could engraft and persist; no species rationale stated
“The transplanted Apligraf® remained durable, as demonstrated by the persistence of human keratinocytes and fibroblasts, for at least one year in the nude mice.”
✓ VerifiedFDA pharmacology/toxicology review, p. 48Source ↗
Surrogate molecule
No surrogate; clinical construct (Apligraf) grafted onto nude mice
“Apligraf® appeared to function as a skin graft (i.e., healing by primary intention) in the nude mouse full-thickness wound model.”
✓ VerifiedFDA pharmacology/toxicology review, p. 49Source ↗
Species: general tox
Not conducted (no chronic toxicology); ISO-10993 biocompatibility tests only
“consisting of pharmacokinetics, acute toxicology, chronic toxicology, genotoxicity, carcinogenicity, reproductive and developmental toxicity, safety pharmacology, and immunotoxicity (http://www.ich.org/cache/compo/276-254-1.html) were not conducted due to the nature of Apligraf® and the extensive clinical experience in the cutaneous indications.”
✓ VerifiedFDA pharmacology/toxicology review, p. 49Source ↗
Species: DART
Not conducted (nature of product and clinical experience)
“consisting of pharmacokinetics, acute toxicology, chronic toxicology, genotoxicity, carcinogenicity, reproductive and developmental toxicity, safety pharmacology, and immunotoxicity (http://www.ich.org/cache/compo/276-254-1.html) were not conducted due to the nature of Apligraf® and the extensive clinical experience in the cutaneous indications.”
✓ VerifiedFDA pharmacology/toxicology review, p. 49Source ↗
Species: carcinogenicity
Not conducted (nature of product and clinical experience)
“consisting of pharmacokinetics, acute toxicology, chronic toxicology, genotoxicity, carcinogenicity, reproductive and developmental toxicity, safety pharmacology, and immunotoxicity (http://www.ich.org/cache/compo/276-254-1.html) were not conducted due to the nature of Apligraf® and the extensive clinical experience in the cutaneous indications.”
✓ VerifiedFDA pharmacology/toxicology review, p. 49Source ↗
Surrogate used in
No surrogate used; clinical product (Apligraf) grafted in nude mouse wound model
“Apligraf® appeared to function as a skin graft (i.e., healing by primary intention) in the nude mouse full-thickness wound model.”
✓ VerifiedFDA pharmacology/toxicology review, p. 49Source ↗